Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-023279
Filing Date
2025-08-12
Accepted
2025-08-12 21:48:05
Documents
1
Period of Report
2025-08-08

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4057
  Complete submission text file 0001641172-25-023279.txt   5564
Mailing Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE SUITE 260 GAITHERSBURG MD 20879 (240) 403-4212
Shuttle Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001757499 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SHUTTLE PHARMACEUTICALS HOLDINGS, INC. 401 PROFESSIONAL DRIVE, SUITE 260 GAITHERSBURG MD 20879
Business Address
Nabyt Oleh (Reporting) CIK: 0002060299 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41488 | Film No.: 251208705